Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to risk of different breast cancer subgroups: a Malmö Diet and Cancer Study

Cancer Causes and Control

Volumn 26, Issue 8, 2015, Pages 1093-1104

  Brandt, Jasmine ^a   Borgquist, Signe ^a,b   Manjer, Jonas ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Aggressiveness; Breast cancer risk; Prospective; Subgroups; Thyroid hormones; Thyroid peroxidase antibodies

Indexed keywords

CYCLIN D1; ESTROGEN RECEPTOR; KI 67 ANTIGEN; LIOTHYRONINE; PROGESTERONE RECEPTOR; PROTEIN P27; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE; ANTIBODY; CCND1 PROTEIN, HUMAN; CYCLINE; IODIDE PEROXIDASE; P27 ANTIGEN;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIOTHYRONINE BLOOD LEVEL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MIDDLE AGED; ONCOLOGICAL PARAMETERS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TUMOR AGGRESSIVENESS; TUMOR VOLUME; AGED; BLOOD; BREAST; BREAST NEOPLASMS; IMMUNOLOGY; METABOLISM; PATHOLOGY; RISK; SWEDEN;

AGED; ANTIBODIES; BREAST; BREAST NEOPLASMS; CYCLIN D1; FEMALE; HUMANS; IODIDE PEROXIDASE; KI-67 ANTIGEN; MIDDLE AGED; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK; SWEDEN; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 84937640190     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-015-0602-8     Document Type: Article

References (33)

1. Hall LC, Salazar EP, Kane SR, Liu N (2008) Effects of thyroid hormones on human breast cancer cell proliferation. J Steroid Biochem Mol Biol 109(18328691):57–66
2. Conde I, Paniagua R, Zamora J, Blanquez MJ, Fraile B, Ruiz A, Arenas MI (2006) Influence of thyroid hormone receptors on breast cancer cell proliferation. Ann Oncol 17(16282247):60–64
3. Shao ZM, Sheikh MS, Rishi AK, Dawson MI, Li XS, Wilber JF, Feng P, Fontana JA (1995) Thyroid hormone enhancement of estradiol stimulation of breast carcinoma proliferation. Exp Cell Res 218(7737350):1–8
4. Nogueira CR, Brentani MM (1996) Triiodothyronine mimics the effects of estrogen in breast cancer cell lines. J Steroid Biochem Mol Biol 59(9010319):271–279
5. Muller I, Giani C, Zhang L, Grennan-Jones FA, Fiore E, Belardi V, Rosellini V, Funel N, Campani D, Giustarini E, Lewis MD, Bakhsh AD, Roncella M, Ghilli M, Vitti P, Dayan CM, Ludgate ME (2014) Does thyroid peroxidase provide an antigenic link between thyroid autoimmunity and breast cancer? Int J Cancer 134(7):1706–1714
6. Tosovic A, Becker C, Bondeson A-G, Bondeson L, Ericsson U-B, Malm J, Manjer J (2012) Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk. Int J Cancer 131(9):2126–2133
7. Tosovic A, Bondeson A-G, Bondeson L, Ericsson U-B, Malm J, Manjer J (2010) Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women. Breast Cancer Res 12 (20540734)
8. Kuijpens JLP, Nyklictek I, Louwman MWJ, Weetman TAP, Pop VJM, Coebergh J-WW (2005) Hypothyroidism might be related to breast cancer in post-menopausal women. Thyroid 15(16356089):1253–1259
9. Hellevik AI, Asvold BO, Bjoro T, Romundstad PR, Nilsen TIL, Vatten LJ (2009) Thyroid function and cancer risk: a prospective population study. Cancer Epidemiol Biomarkers Prev 18(19155436):570–574
10. Tosovic A, Bondeson A-G, Bondeson L, Ericsson U-B, Manjer J (2014) T3 levels in relation to prognostic factors in breast cancer: a population-based prospective cohort study. BMC Cancer 14:536
11. Manjer J, Carlsson S, Elmstahl S, Gullberg B, Janzon L, Lindstrom M, Mattisson I, Berglund G (2001) The Malmö diet and cancer study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev 10(6):489–499
12. Almquist M, Bondeson A-G, Bondeson L, Malm J, Manjer J (2010) Serum levels of vitamin D, PTH and calcium and breast cancer risk—a prospective nested case–control study. Int J Cancer 127(20112341):2159–2168
13. Elston CW, Ellis IO (2002) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 41(3A):151–152; 19:403–410 (1991); discussion 152–153
14. Borgquist S, Anagnostaki L, Jirstrom K, Landberg G, Manjer J (2007) Breast tumors following combined hormone replacement therapy express favourable prognostic factors. Int J Cancer 120(10):2202–2207. doi:10.1002/ijc.22542
15. Rudas M, Lehnert M, Huynh A, Jakesz R, Singer C, Lax S, Schippinger W, Dietze O, Greil R, Stiglbauer W, Kwasny W, Grill R, Stierer M, Gnant MFX, Filipits M (2008) Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy. Clin Cancer Res 14(18347178):1767–1774
16. Dowsett M, Nielsen TO, A’Hern R, Bartlett J, Coombes RC, Cuzick J, Ellis M, Henry NL, Hugh JC, Lively T, McShane L, Paik S, Penault-Llorca F, Prudkin L, Regan M, Salter J, Sotiriou C, Smith IE, Viale G, Zujewski JA, Hayes DF (2011) Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. J Natl Cancer Inst 103(21960707):1656–1664
17. Cancer Incidence in Sweden 2011 (2012). The national board of health and welfare, p 80. http://www.socialstyrelsen.se/publikationer2012/2012-12-19. Accesseed 6 May 2015
18. Garne J (1996) Invasive breast cancer in Malmö 1961–1992—an epidemiological study
19. Camp RL, Charette LA, Rimm DL (2000) Validation of tissue microarray technology in breast carcinoma. Lab Investig 80(11140706):1943–1949
20. Mannisto T, Suvanto E, Surcel H-M, Ruokonen A (2010) Thyroid hormones are stable even during prolonged frozen storage. Clin Chem Lab Med 48(20961202):1669–1670
21. Mannisto T, Surcel H-M, Bloigu A, Ruokonen A, Hartikainen A-L, Jarvelin M-R, Pouta A, Vaarasmaki M, Suvanto-Luukkonen E (2007) The effect of freezing, thawing, and short- and long-term storage on serum thyrotropin, thyroid hormones, and thyroid autoantibodies: implications for analyzing samples stored in serum banks. Clin Chem 53(17954505):1986–1987
22. Lemaire M, Baugnet-Mahieu L (1986) Thyroid function in women with breast cancer. Eur J Cancer Clin Oncol 22(3709598):301–307
23. Rasmusson B, Feldt-Rasmussen U, Hegedus L, Perrild H, Bech K, Hoier-Madsen M (1987) Thyroid function in patients with breast cancer. Eur J Cancer Clin Oncol 23(3653178):553–556
24. Rose DP, Davis TE (1979) Plasma triiodothyronine concentrations in breast cancer. Cancer 43(445341):1434–1438
25. Borgquist S, Jirstrom K, Anagnostaki L, Manjer J, Landberg G (2009) Anthropometric factors in relation to different tumor biological subgroups of postmenopausal breast cancer. Int J Cancer 124(18798278):402–411
26. Slanger TE, Chang-Claude JC, Obi N, Kropp S, Berger J, Vettorazzi E, Braendle W, Bastert G, Hentschel S, Flesch-Janys D (2009) Menopausal hormone therapy and risk of clinical breast cancer subtypes. Cancer Epidemiol Biomarkers Prev 18(19336542):1188–1196
27. Abe R, Hirosaki A, Kimura M (1980) Pituitary-thyroid function in patients with breast cancer. Tohoku J Exp Med 132(6777905):231–236
28. Zumoff B, O’Connor J, Levin J, Markham M, Strain GW, Fukushima DK (1981) Plasma levels of thyroxine and triiodothyronine in women with breast cancer. Anticancer Res 1(7345972):287–291
29. Giustarini E, Pinchera A, Fierabracci P, Roncella M, Fustaino L, Mammoli C, Giani C (2006) Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur J Endocrinol 154(16645010):645–649
30. Gogas J, Kouskos E, Tseleni-Balafouta S, Markopoulos C, Revenas K, Gogas G, Kostakis A (2001) Autoimmune thyroid disease in women with breast carcinoma. Eur J Surg Oncol 27(11669589):626–630
31. Giani C, Fierabracci P, Bonacci R, Gigliotti A, Campani D, De Negri F, Cecchetti D, Martino E, Pinchera A (1996) Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab 81(3):990–994
32. Michalaki V, Kondi-Pafiti A, Gennatas S, Antoniou A, Primetis H, Gennatas C (2009) Breast cancer in association with thyroid disorders. J BUON 14(19810133):425–428
33. Turken O, NarIn Y, DemIrbas S, Onde ME, Sayan O, KandemIr EG, YaylacI M, Ozturk A (2003) Breast cancer in association with thyroid disorders. Breast Cancer Res 5(12927040):110–113